These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9694604)

  • 21. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
    Hedgepeth RC; Yang L; Resnick MI; Marengo SR
    Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.
    Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Piaseu N; Chansirikam S; Puavilai G; Rajatanavin R
    Osteoporos Int; 2000; 11(6):486-92. PubMed ID: 10982163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
    Tiselius HG; Sandvall K
    Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation.
    Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D
    Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
    Karagülle O; Smorag U; Candir F; Gundermann G; Jonas U; Becker AJ; Gehrke A; Gutenbrunner C
    World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate.
    Berg C; Larsson L; Tiselius HG
    Urol Res; 1990; 18(1):13-6. PubMed ID: 2316066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
    Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
    Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
    Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.